Hutchinson Institute for Cancer Outcomes Research

Faculty and Collaborators

HICOR

HICOR is comprised of faculty from Fred Hutchinson Cancer Research Center, University of Washington and Seattle Cancer Care Alliance.


HICOR Director

Scott Ramsey, MD, PhD

Scott Ramsey, MD, PhD

  • Member, Public Health Sciences Division, Fred Hutchinson Cancer Research Center
  • Adjunct Professor, Department of Health Services, University of Washington
  • Professor of Medicine, Division of General Internal Medicine, University of Washington
  • Professor (Adjunct), Pharmaceutical Outcomes, Research, and Policy Program, Department of Pharmacy, University of Washington

Dr. Ramsey studies comparative effectiveness analysis; cost effectiveness analysis, health economics, cancer outcomes research. 

Read more about Dr. Ramsey »

 

Dr. Gary Lyman

HICOR Co-Director

Gary Lyman, MD, MPH

  • Practicing medical oncologist
  • Member, Public Health Sciences Division, Fred Hutchinson Cancer Research Center
  • Affiliate Professor, Department of Health Services, University of Washington
  • Affiliate Professor, Department of Pharmacy, University of Washington

Dr. Gary Lyman is practicing medical oncologist and is nationally and internationally recognized for his leadership in comparative effectiveness, health services and outcomes research.  
Read more about Dr. Lyman's appointment as co-director of HICOR
»

Read more about Dr. Lyman »

Faculty and Collaborators

Garnet Anderson

Garnet Anderson

Member and Director, Public Health Sciences Division

Dr. Anderson's research centers on methods for multicenter studies of women's health.

Anirban Basu, PhD

Anirban Basu, PhD

Associate Professor, Health Services, University of Washington
Adjunct Associate Professor, Economics, University of Washington
Adjunct Associate Professor, Pharmacy, University of Washington

Dr. Basu’s research interests include methods and applications that study observed and unobserved heterogeneity in clinical and economic outcomes.

http://faculty.washington.edu/basua/

Carrie Bennette, MPH

Carrie Bennette, MPH

Carrie Bennette is a PhD student in the Pharmaceutical Outcomes Research and Policy Program (PORPP) with a background in biostatistics and health outcomes research.  She is broadly interested in comparative effectiveness research of cancer treatment and control strategies and in methodological work to support such research.

Jonathan B. Bricker, PhD

Dr. Jonathan Bricker

Associate Member, Public Health Sciences Division, Fred Hutchinson Cancer Research Center

Dr. Bricker researches novel behavioral interventions (e.g., Acceptance and Commitment Therapy) for changing health behavior delivered at the public health level and psychosocial influences on health behavior over the course of the lifespan.

Josh Carlson, PhD

Assistant Professor, Pharmaceutical Outcomes Research and Policy Program, University of Washington
Affiliate Member, Public Health Sciences Division, Fred Hutchinson Cancer Research Center

Dr. Carlson's current research interests and work to date has primarily focused on the intersection of three areas: 1) genomics and emerging technologies in the field of personalized medicine, 2) uncertainty both in our decision-making processes and as the concept applies to the application of medical technologies in "real world" settings (i.e. outside of clinical trials) including comparative effectiveness research, and 3) economic and policy options to address these uncertainties as we seek to improve our healthcare system and the health of our population.

Bernardo Goulart, MD, MS

Dr. Bernardo Goulart

Affiliate Investigator, Public Health Sciences Division, FHCRC
Research Associate, Clinical Research Division, FHCRC
Acting Instructor, University of Washington School of Medicine
Attending Physician, Seattle Cancer Care Alliance (SCCA)

Dr. Goulart is a medical oncologist who specializes in caring for patients with lung cancer and head and neck cancers. His research expertise includes cancer outcomes, economic evaluation of cancer therapies for lung, head and neck cancers, cost-effectiveness and quality of life impact of lung cancer screening, and studies of access and utilization of healthcare resources for lung and head and neck cancers.

Richard Kim, MD

Dr. Richard Kim

Senior Fellow, Pulmonary and Critical Care Medicine, University of Washington School of Medicine
PhD student, Pharmaceutical Outcomes Research and Policy Program, University of Washington

Dr. Kim is a senior fellow in pulmonary/critical care medicine who sees patients with lung diseases and suspected lung cancer at the Seattle Cancer Care Alliance. His primary research focus is on the cost of lung cancer diagnosis. He also maintains interests in cost-effectiveness research and patterns of health care utilization in tuberculosis, critical care illness, and sleep medicine.

Michael LeBlanc, PhD

Michael LeBlanc, PhD

Member, Public Health Sciences Division

Dr. LeBlance uses statistical methods for clinical trials, adaptive and non-parametric regression models, survival analysis.

 

Christoph Lee, MD, MSHS

Dr. Christoph Lee

Radiologist, Breast Imaging, Seattle Cancer Care Alliance

Dr. Lee's research interests include adjunct breast cancer screening technologies and appropriate advanced imaging utilization, with expertise in cost-effectiveness analysis and technology assessment.

Janie M. Lee, MD, MSc

Janie M. Lee, MD, M.Sc.

Associate Professor, University of Washington
Clinical Director, Breast Imaging, Seattle Cancer Care Alliance

Dr. Lee's research focuses on integrating information about patient risk factors, cancer biology, and emerging technologies to develop more personalized breast cancer screening and surveillance regimens and to improve population level outcomes.

Constance Lehman, MD, PhD

Dr. Constance Lehman

Director of Imaging, Seattle Cancer Care Alliance
Breast Imaging Section Head and Professor, School of Medicine, University of Washington
Public Health Sciences Joint Member, Fred Hutchinson Cancer Research Center
Affiliate Investigator, Group Health Cooperative

Dr. Lehman's research interests are focused on new methods and applications of MRI in breast imaging and in factors that influence the performance of mammography in early cancer detection.

Jean McDougall, PhD, MPH

Jean McDougall, PhD, MPH

Jean McDougall is a postdoctoral fellow with the Hutchinson Institute for Cancer Outcomes Research at the Fred Hutchinson Cancer Research Center. Dr. McDougall received her PhD in Epidemiology from the University of Washington. Her research interests include socioeconomic disparities and the measurement and monitoring of the economic burden of cancer screening and treatment.

Bonnie McGregor, PhD

Bonnie McGregor, PhD

Associate Member, Public Health Sciences Division

Dr. McGregor stuides psychological interventions; nervous, endocrine and immune system interactions.

Carol Moinpour, PhD

Carol Moinpour, PhD

Member, Public Health Sciences Division

Dr. Moinpour researches behavioral science in cancer clinical trials research and quality of life outcomes.

Megan Othus, PhD

Megan Othus, PhD

Assistant Member, Public Health Sciences Division, Fred Hutchinson Cancer Research Center

Dr. Orthus studies survival analysis, cure modeling, change-point problems, longitudinal and multivariate data analysis

Joshua A. Roth, PhD, MHA

Dr. Joshua Roth

Kirschstein NRSA T32 Fellow, Group Health Research Institute
Post-Doctoral Fellow, Fred Hutchinson Cancer Research Center

Dr. Roth is researching the comparative effectiveness researcher with a background in health economics, epidemiology, and health services management. Specialties include application of regression modeling, meta-analysis, and decision modeling methods to evaluate chronic disease health outcomes.

Veena Shankaran, MD, MS

Dr. Veena Shankaran

Assistant Professor, Medical Oncology, University of Washington School of Medicine
Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center

Dr. Shankaran is a medical oncologist who specializes in caring for patients with gastrointestinal malignancies, with a particular focus on cancers of the esophagus and stomach. Her research expertise includes health economics and comparative effectiveness, with a focus on patterns of care and risk factors for financial hardship among cancer patients.

Mohamed Sorror, MD

Mohamed Sorror

Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
Assistant Professor of Medicine, University of Washington

Dr. Sorror is studying the impacts of medical comorbidities on outcomes of hematopoietic cell transplantation (HCT) for hematologic malignancies in order to improve decision-making and lessen the HCT morbidity and mortality.

Sean D. Sullivan, BScPharm, PhD, MS

Dr. Sean Sullivan

Stergachis Family Professor, Department of Pharmacy, University of Washington
Director, Pharmaceutical Outcomes Research and Policy Program (PORPP) and the CHASE Alliance K12 Patient-Centered Outcomes Research Scholars Program
Professor, Health Services, University of Washington

Dr. Sullivan's research interests include technology assessment; medical decision-making; economic evaluation of health care technologies, particularly in the areas of respiratory disorders, cancer, and HCV.

Beti Thompson, PhD

Dr. Beti Thompson

Member, Public Health Sciences Division, Fred Hutchinson Cancer Research Center

Dr. Thompson researches community approaches to reducing cancer and other health disparities in minority and other underserved populations, both in the US and abroad.

Nicole Urban, PhD

Nicole Urban, PhD

Member, Public Health Sciences Division

Health Services Research Professor, University of Washington

Dr. Urban researches the promotion, surveillance and cost-effectiveness of cancer screening.

David Veenstra, PharmD, PhD

David Veenstra, PharmD, PhD

Professor, School of Pharmacy

Dr. Veenstra’s research interests include clinical, economic, and policy implications of using genomic information in healthcare.


Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.